help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shupnik, M. A.
Right arrow Articles by Ridgway, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shupnik, M. A.
Right arrow Articles by Ridgway, E. C.

Endocrinology, Vol 117, 1940-1946, Copyright © 1985 by Endocrine Society


ARTICLES

Triiodothyronine rapidly decreases transcription of the thyrotropin subunit genes in thyrotropic tumor explants

MA Shupnik and EC Ridgway

We have investigated the direct effect of the thyroid hormone T3 on the TSH subunit genes in tissue explants. Minces of TtT 97 thyrotropic tumor were treated with 5 nM T3 for varying periods of time. Nuclei were then isolated from the tumor cells and allowed to continue RNA synthesis in the presence of [alpha-32P]UTP. Newly synthesized RNA sequences were quantified by hybridization to immobilized cloned cDNAs containing sequences specific for either TSH beta or alpha-subunit mRNA. Basal TSH beta and alpha-subunit mRNA synthesis rates were both approximately 300-400 parts/million, the same as in vivo values. After 15 min of T3 treatment, TSH beta mRNA synthesis was significantly decreased by 42% and was maximally decreased by 95% after 1 or more hours of T3. Synthesis of alpha-subunit mRNA was decreased by 38% after 30 min of T3 treatment and by 78% after 1 h or more of T3. The suppressive effects of T3 on transcription correlated with the time course of T3 binding to its nuclear receptor. These changes are quantitatively similar to those observed after in vivo T3 treatment. Decreases in mRNA synthesis preceded significant decreases in tissue steady state mRNA levels or subunit protein levels. The presence of the protein synthesis inhibitor cycloheximide (25 micrograms/ml) during a 4- h incubation with T3 did not change the T3-mediated decreases in TSH beta or alpha-subunit mRNA synthesis or the decreases in cellular mRNA levels. Therefore, T3 can act directly on the thyrotrope to suppress TSH beta and alpha-subunit mRNA synthesis, and protein synthesis is not necessary for the T3-mediated decreases in gene transcription. The data suggest that T3 may act directly at the level of the TSH subunit genes to modulate their expression.


This article has been cited by other articles:


Home page
EndocrinologyHome page
F. Goulart da Silva, G. Giannocco, M. F. Santos, and M. T. Nunes
Thyroid Hormone Induction of Actin Polymerization in Somatotrophs of Hypothyroid Rats: Potential Repercussions in Growth Hormone Synthesis and Secretion
Endocrinology, December 1, 2006; 147(12): 5777 - 5785.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Takeuchi, Y. Murata, P. Sadow, Y. Hayashi, H. Seo, J. Xu, B. W. O'Malley, R. E. Weiss, and S. Refetoff
Steroid Receptor Coactivator-1 Deficiency Causes Variable Alterations in the Modulation of T3-Regulated Transcription of Genes in Vivo
Endocrinology, April 1, 2002; 143(4): 1346 - 1352.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. F. Gordon, W. W. Woodmansee, S. R. Lewis, R. A. James, W. M. Wood, and E. C. Ridgway
Cloning of the Mouse Somatostatin Receptor Subtype 5 Gene: Promoter Structure and Function
Endocrinology, December 1, 1999; 140(12): 5598 - 5608.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. M. Staton and P. J. Leedman
Posttranscriptional Regulation of Thyrotropin {beta}-Subunit Messenger Ribonucleic Acid by Thyroid Hormone in Murine Thyrotrope Tumor Cells: A Conserved Mechanism across Species
Endocrinology, March 1, 1998; 139(3): 1093 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
V. D. Sarapura, H. L. Strouth, D. F. Gordon, W. M. Wood, and E. C. Ridgway
Msx1 Is Present in Thyrotropic Cells and Binds to a Consensus Site on the Glycoprotein Hormone {alpha}-Subunit Promoter
Mol. Endocrinol., November 1, 1997; 11(12): 1782 - 1794.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
R. A. James, V. D. Sarapura, C. Bruns, F. Raulf, J. M. Dowding, D. F. Gordon, W. M. Wood, and E. C. Ridgway
Thyroid Hormone-Induced Expression of Specific Somatostatin Receptor Subtypes Correlates with Involution of the TtT-97 Murine Thyrotrope Tumor
Endocrinology, February 1, 1997; 138(2): 719 - 724.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society